{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:10:17Z","timestamp":1756293017857,"version":"3.44.0"},"reference-count":29,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,12,1]]},"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>We report a case of a patient presenting with subacute neurological symptoms 10 years postkidney transplant. Cognitive deficits included acalculia and left upper limb dysesthesia, progressing to hemiplegic upper motor neuron weakness. Investigations included an MRI with multiple FLAIR hyperintensities, while a lumbar puncture was sterile with negative flow cytometry. Ultimately, PCR testing for John Cunningham virus was positive on cerebrospinal fluid. The diagnosis of progressive multifocal leukoencephalopathy (PML) was confirmed on the basis of the above.<\/jats:p>\n               <jats:p>Initially, the patient was managed with withdrawal of immunosuppressants and close observation. Mirtazapine was commenced based on case reports of successful use in non-transplant patients; the patient\u2019s recovery was temporally related to withdrawal of immunosuppression and increasing mirtazapine dosage. The patient is currently maintained on prednisolone and mirtazapine with stable graft function and improved mobility and cognitive function.<\/jats:p>","DOI":"10.1136\/bcr-2022-252284","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T11:00:00Z","timestamp":1670929200000},"page":"e252284","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Progressive multifocal leukoencephalopathy 10 years following transplant: 5HT receptor antagonism as an adjunct to immune reconstitution"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-0060","authenticated-orcid":false,"given":"Shaun","family":"Chandler","sequence":"first","affiliation":[{"name":"Metro North Kidney Health Service, Queensland Health, Brisbane, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Isbel","sequence":"additional","affiliation":[{"name":"Metro South Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia"},{"name":"The University of Queensland Faculty of Medicine, Herston, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"2025082703475633000_15.12.e252284.1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22408"},{"key":"2025082703475633000_15.12.e252284.2","doi-asserted-by":"publisher","DOI":"10.1177\/1756285615602832"},{"key":"2025082703475633000_15.12.e252284.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)91777-6"},{"key":"2025082703475633000_15.12.e252284.4","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-013-0222-6"},{"key":"2025082703475633000_15.12.e252284.5","doi-asserted-by":"publisher","DOI":"10.1086\/597126"},{"key":"2025082703475633000_15.12.e252284.6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/81.1.93"},{"key":"2025082703475633000_15.12.e252284.7","doi-asserted-by":"publisher","DOI":"10.3109\/13550289809113482"},{"key":"2025082703475633000_15.12.e252284.8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-1-78"},{"key":"2025082703475633000_15.12.e252284.9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.autrev.2012.10.020","article-title":"Different effects of biological drugs in rheumatoid arthritis","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2025082703475633000_15.12.e252284.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00800.x"},{"key":"2025082703475633000_15.12.e252284.11","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.4.903-925.2004"},{"key":"2025082703475633000_15.12.e252284.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.02.339"},{"key":"2025082703475633000_15.12.e252284.13","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-013-1471-0"},{"key":"2025082703475633000_15.12.e252284.14","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-013-0173-y"},{"key":"2025082703475633000_15.12.e252284.15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.healun.2016.10.009","article-title":"JC virus encephalopathy in a lung transplant recipient: novel presentation of an old virus","volume":"36","author":"Hamad","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2025082703475633000_15.12.e252284.16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/ajt.12153","article-title":"Progressive multifocal leukoencephalopathy in a heart transplant recipient following rituximab therapy for antibody-mediated rejection","volume":"13","author":"Loyaga-Rendon","year":"2013","journal-title":"Am J Transplant"},{"key":"2025082703475633000_15.12.e252284.17","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12850","article-title":"Progressive multifocal leukoencephalopathy after T-cell replete HLA-haploidentical transplantation with post-transplantation cyclophosphamide graft-versus-host disease prophylaxis","volume":"20","author":"Ikegawa","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2025082703475633000_15.12.e252284.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.07.018"},{"key":"2025082703475633000_15.12.e252284.19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5582\/irdr.2019.01107","article-title":"A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of john cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with mirtazapine, olanzapine and foscarnet","volume":"8","author":"Pasca","year":"2019","journal-title":"Intractable Rare Dis Res"},{"key":"2025082703475633000_15.12.e252284.20","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13293","article-title":"Progressive multifocal leukoencephalopathy in a lung transplant recipient presenting with memory impairment: case report and literature review","volume":"22","author":"Crowhurst","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"2025082703475633000_15.12.e252284.21","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13304","article-title":"Progressive multifocal leukoencephalopathy presenting with acute sensorineural hearing loss in an intestinal transplant recipient","volume":"22","author":"Lippa","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"2025082703475633000_15.12.e252284.22","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3201\/eid2511.190705","article-title":"Effectiveness of immune checkpoint inhibitors in transplant recipients with progressive multifocal leukoencephalopathy","volume":"25","author":"Medrano","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2025082703475633000_15.12.e252284.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2008.12.010"},{"key":"2025082703475633000_15.12.e252284.24","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13162","article-title":"A case of immune reconstitution syndrome complicating progressive multifocal leukoencephalopathy after kidney transplant: clinical, pathological, and radiographic features","volume":"21","author":"Jackowiak","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"2025082703475633000_15.12.e252284.25","first-page":"281","article-title":"[A patient with progressive multifocal leukoencephalopathy who developed b\u00e1lint syndrome improved by combination therapy using mefloquine and mirtazapine]","volume":"71","author":"Takekoshi","year":"2019","journal-title":"Brain Nerve"},{"key":"2025082703475633000_15.12.e252284.26","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu682"},{"key":"2025082703475633000_15.12.e252284.27","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010047","article-title":"Adoptive T cell therapy strategies for viral infections in patients receiving haematopoietic stem cell transplantation","volume":"8","author":"Ottaviano","year":"2019","journal-title":"Cells"},{"key":"2025082703475633000_15.12.e252284.28","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.221"},{"key":"2025082703475633000_15.12.e252284.29","article-title":"Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors","author":"Boumaza","year":"2022","journal-title":"Ann Neurol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-252284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:48:03Z","timestamp":1756291683000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-252284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,13]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/bcr-2022-252284"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-252284","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}